Correlation Between Eterna Therapeutics and Mesoblast

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Mesoblast, you can compare the effects of market volatilities on Eterna Therapeutics and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Mesoblast.

Diversification Opportunities for Eterna Therapeutics and Mesoblast

-0.03

Correlation Coefficient

Eterna Therapeutics  Mesoblast

Good diversification

The 3 months correlation between Eterna and Mesoblast is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Mesoblast go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Mesoblast

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Mesoblast. But the stock apears to be less risky and, when comparing its historical volatility, Eterna Therapeutics is 1.01 times less risky than Mesoblast. The stock trades about -0.04 of its potential returns per unit of risk. The Mesoblast is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  646.00  in Mesoblast on December 3, 2024 and sell it today you would earn a total of  1,069  from holding Mesoblast or generate 165.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	97.78%
Values	Daily Returns

Eterna Therapeutics  vs.  Mesoblast

Eterna Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eterna Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Eterna Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Mesoblast

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eterna Therapeutics and Mesoblast

The main advantage of trading using opposite Eterna Therapeutics and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.

The idea behind Eterna Therapeutics and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.